Fact Sheet - U.S. Government Awards $245,000 to Uganda Virus Research Institute (Uvri), Preserving 90 Years of American and Ugandan Scientific Partnership

The United States Government has awarded $245,000 to the Uganda Virus Research Institute (Uvri), marking a significant milestone in the preservation of 90 years of American and Ugandan scientific partnership. This funding is intended to support research and development at Uvri, further solidifying the institution's position as a leading center for virus research in Africa.

The U.S. Embassy Kampala has announced that it will be awarding $245,000 to the Uganda Virus Research Institute (Uvri), preserving a long-standing partnership between American and Ugandan scientists. This development is significant not only for its financial implications but also for the enduring legacy of scientific collaboration between the two nations.

The partnership between the United States Government and Uvri dates back to 1933, when the Rockefeller Foundation established the Yellow Fever Research Institute in Entebbe, Uganda. Over the years, this institution has undergone several transformations, eventually becoming the Uganda Virus Research Institute (Uvri). The institute's research focus has expanded to include various virus-related diseases, making it a crucial player in Africa's fight against infectious diseases.

The awarding of $245,000 to Uvri by the U.S. Embassy Kampala is a testament to the enduring nature of American-Ugandan scientific collaboration. This partnership has been instrumental in advancing our understanding of various virus-related diseases and has contributed significantly to public health efforts on the continent. The financial support will undoubtedly enable Uvri to continue its vital research and development work, further solidifying its position as a leading center for virus research in Africa.

The preservation of this partnership is a significant achievement, not only for the scientific community but also for the people of Uganda and the broader African region. As we move forward, it will be essential to continue investing in institutions like Uvri, which play a critical role in advancing our understanding of infectious diseases and improving public health outcomes.